IBCSG 35-07 (SOLE) / ICORG 11-03 Study
ICORG exceeded their accrual target for IBCSG35-07 (SOLE) / ICORG 11-03 Study
Uncategorised
ICORG Abstract at ESMO 2012
ICORG has had an abstract accepted for ESMO 2012 on "Serum levels of VEGF pre- and post-treatment with bevacizumab for early stage breast cancer" [ICORG 08-10 Study]
Fighting Cancer Triathlon 2012
The Fighting Cancer Triathlon took place on Saturday 16th June 2012 in Belvedere House & Gardens, Mullingar, Co Westmeath.
Everolimus in Advanced Breast Cancer
Recent data is indicating Everolimus in combination with a Hormonal therapy as a potential new combination treatment regime for advanced breast cancer patients.
ICORG’s Leading Role in Cancer Research in Ireland recognised by Irish Medicines Board
ICORG’s Leading Role in Cancer Research in Ireland recognised by Irish Medicines Board.
ICORG co-author on Oral Presentation at ASCO Annual Meeting 2012
ICORG is a co-author on Oral Presentation at ASCO Annual Meeting 2012.
International Clinical Trials Day
International Clinical Trials’ Day is celebrated around the world on or near the 20th of May.
Pivotal Role that Clinical Trials play in Cancer Research
Recent coverage in the media has highlighted the importance of having Clinical Trials as options in Cancer Treatment. ICORG has approximately 50 active Cancer Clinical Trials and has plans to open a further 30 trials in 2012, in many disease areas including Breast, Lung and Melanoma.
ICORG GCO News
Robert Byrne joined ICORG in January in the role of Clinical Project Manager.
Fighting Cancer on the Home Front
ICORG was featured in this Irish Times article (30-Mar-2012) which explains how much cancer research has advanced and is continuing to do so in Ireland.